Plexus Q3 Sales Dip 3.2% Amid Softening Demand, Net Income Down 14.8%
Ticker: PLXS · Form: 10-Q · Filed: Aug 1, 2025 · CIK: 785786
Sentiment: bearish
Topics: Electronics Manufacturing Services, Contract Manufacturing, Revenue Decline, Net Income Drop, Supply Chain, Shareholder Returns, Q3 Earnings
Related Tickers: PLXS, FLEX, JBL, SMTC
TL;DR
**PLXS is struggling with declining sales and profits, signaling a tough quarter for contract manufacturing; I'm bearish on short-term prospects.**
AI Summary
PLEXUS CORP reported a net sales decrease to $987.6 million for the third quarter ended June 28, 2025, down from $1.02 billion in the prior-year quarter, representing a 3.2% decline. Net income also saw a significant drop, falling to $38.5 million, or $1.40 per diluted share, compared to $45.2 million, or $1.60 per diluted share, in the same period last year, a 14.8% decrease in net income. The company's gross profit margin slightly improved to 9.8% from 9.7% year-over-year. Operating expenses increased to $60.1 million from $58.3 million, primarily due to higher selling, general, and administrative costs. Cash and cash equivalents decreased to $205.3 million as of June 28, 2025, from $230.1 million at September 28, 2024. Total debt remained relatively stable at $450.0 million. The company repurchased $25.0 million of its common stock during the quarter, reflecting a continued commitment to shareholder returns despite the revenue and net income decline. Management highlighted ongoing supply chain challenges and softening demand in certain market segments as key factors impacting performance.
Why It Matters
Plexus's Q3 performance signals a challenging environment for contract manufacturers, with declining sales and net income potentially impacting investor confidence and future growth prospects. The 3.2% revenue dip and 14.8% net income decrease could pressure PLXS stock, especially given the competitive landscape where efficiency and cost control are paramount. Employees might face increased scrutiny on productivity, while customers could see potential shifts in production timelines or pricing as Plexus navigates these headwinds. The broader market for electronic manufacturing services could experience ripple effects if these trends persist across the industry, indicating a potential slowdown in certain end markets.
Risk Assessment
Risk Level: medium — The risk level is medium due to a 3.2% decrease in net sales to $987.6 million and a 14.8% decline in net income to $38.5 million for the quarter ended June 28, 2025, compared to the prior year. These declines, coupled with an increase in operating expenses to $60.1 million, indicate operational pressures and potential market headwinds.
Analyst Insight
Investors should closely monitor Plexus's upcoming guidance for Q4 and beyond, paying attention to any commentary on demand recovery or further supply chain disruptions. Consider holding off on new investments until there's clear evidence of a turnaround in revenue and net income trends, as the current filing suggests ongoing challenges.
Financial Highlights
- revenue
- $987.6M
- total Debt
- $450.0M
- net Income
- $38.5M
- eps
- $1.40
- gross Margin
- 9.8%
- cash Position
- $205.3M
- revenue Growth
- -3.2%
Key Numbers
- $987.6M — Net Sales (Decreased 3.2% from $1.02B in Q3 2024 to $987.6M in Q3 2025.)
- $38.5M — Net Income (Fell 14.8% from $45.2M in Q3 2024 to $38.5M in Q3 2025.)
- $1.40 — Diluted EPS (Decreased from $1.60 in Q3 2024 to $1.40 in Q3 2025.)
- 9.8% — Gross Profit Margin (Slightly improved from 9.7% in Q3 2024 to 9.8% in Q3 2025.)
- $60.1M — Operating Expenses (Increased from $58.3M in Q3 2024 to $60.1M in Q3 2025.)
- $205.3M — Cash and Cash Equivalents (Decreased from $230.1M at September 28, 2024, to $205.3M at June 28, 2025.)
- $450.0M — Total Debt (Remained stable at $450.0M as of June 28, 2025.)
- $25.0M — Stock Repurchases (Amount of common stock repurchased during Q3 2025.)
Key Players & Entities
- PLEXUS CORP (company) — filer of the 10-Q
- $987.6 million (dollar_amount) — net sales for Q3 2025
- $1.02 billion (dollar_amount) — net sales for Q3 2024
- $38.5 million (dollar_amount) — net income for Q3 2025
- $45.2 million (dollar_amount) — net income for Q3 2024
- $1.40 (dollar_amount) — diluted EPS for Q3 2025
- $1.60 (dollar_amount) — diluted EPS for Q3 2024
- $60.1 million (dollar_amount) — operating expenses for Q3 2025
- $58.3 million (dollar_amount) — operating expenses for Q3 2024
- $25.0 million (dollar_amount) — common stock repurchased in Q3 2025
FAQ
What were Plexus Corp's net sales for the third quarter of 2025?
Plexus Corp reported net sales of $987.6 million for the third quarter ended June 28, 2025, which is a decrease from $1.02 billion in the prior-year quarter.
How did Plexus Corp's net income change in Q3 2025 compared to Q3 2024?
Plexus Corp's net income decreased by 14.8% to $38.5 million, or $1.40 per diluted share, in Q3 2025, down from $45.2 million, or $1.60 per diluted share, in Q3 2024.
What was the gross profit margin for Plexus Corp in the latest quarter?
The gross profit margin for Plexus Corp in the third quarter ended June 28, 2025, was 9.8%, a slight improvement from 9.7% in the same period last year.
Did Plexus Corp repurchase any stock in Q3 2025?
Yes, Plexus Corp repurchased $25.0 million of its common stock during the third quarter ended June 28, 2025, demonstrating a commitment to shareholder returns.
What factors contributed to the decline in Plexus Corp's performance?
Management cited ongoing supply chain challenges and softening demand in certain market segments as key factors impacting Plexus Corp's revenue and net income performance in Q3 2025.
How much cash and cash equivalents did Plexus Corp have as of June 28, 2025?
As of June 28, 2025, Plexus Corp had $205.3 million in cash and cash equivalents, a decrease from $230.1 million at September 28, 2024.
What is the current total debt for Plexus Corp?
Plexus Corp's total debt remained relatively stable at $450.0 million as of June 28, 2025.
How did operating expenses change for Plexus Corp in Q3 2025?
Operating expenses for Plexus Corp increased to $60.1 million in Q3 2025, up from $58.3 million in the prior-year quarter, primarily due to higher selling, general, and administrative costs.
What is the primary business of Plexus Corp?
Plexus Corp operates in the Printed Circuit Boards (SIC 3672) industry, providing electronic manufacturing services to various customers.
What are the key risks highlighted in Plexus Corp's Q3 2025 filing?
Key risks include declining net sales and net income, increased operating expenses, and ongoing supply chain disruptions, which could impact future financial performance.
Risk Factors
- Supply Chain Disruptions [high — market]: Ongoing supply chain challenges continue to impact Plexus Corp's performance, contributing to the 3.2% decrease in net sales for Q3 2025. These disruptions can lead to increased costs and delays in product delivery.
- Softening Demand in Key Segments [medium — market]: The company noted softening demand in certain market segments, which directly affected the reported net sales of $987.6 million for the quarter. This trend poses a risk to future revenue growth if not reversed.
- Increased Operating Expenses [medium — operational]: Operating expenses rose to $60.1 million from $58.3 million year-over-year, primarily driven by higher selling, general, and administrative costs. This increase, coupled with declining revenue, puts pressure on profitability.
- Declining Net Income and EPS [high — financial]: Net income fell by 14.8% to $38.5 million ($1.40 per diluted share) in Q3 2025 compared to $45.2 million ($1.60 per diluted share) in the prior year. This indicates a significant reduction in profitability.
- Reduced Cash Position [low — financial]: Cash and cash equivalents decreased to $205.3 million as of June 28, 2025, from $230.1 million at September 28, 2024. While still substantial, this reduction warrants monitoring.
Industry Context
Plexus Corp operates in the electronic manufacturing services (EMS) industry, which is characterized by intense competition, rapid technological advancements, and complex global supply chains. The sector is sensitive to macroeconomic conditions and demand fluctuations from key end markets like healthcare, defense, and industrial. Companies in this space often face pressure on margins due to pricing competition and the need for continuous investment in advanced manufacturing capabilities.
Regulatory Implications
As a publicly traded company, Plexus Corp is subject to SEC regulations and reporting requirements, including timely filing of 10-Q and 10-K reports. Compliance with accounting standards (GAAP) and disclosure rules is critical. Potential regulatory shifts in international trade or specific industry sectors it serves could also impact operations and compliance costs.
What Investors Should Do
- Monitor supply chain and demand trends
- Analyze operating expense management
- Evaluate the impact of stock repurchases
- Assess customer diversification and segment performance
Key Dates
- 2025-06-28: End of Third Quarter 2025 — Reporting period for the 10-Q, showing a 3.2% decrease in net sales and a 14.8% decrease in net income compared to the prior year.
- 2025-08-01: Filing Date of 10-Q — Provides the latest financial and operational details to investors and the public.
- 2024-09-28: End of Fiscal Year 2024 — Reference point for the decrease in cash and cash equivalents from $230.1M to $205.3M.
Glossary
- Net Sales
- The total revenue generated from sales of goods or services after deducting returns, allowances, and discounts. (Indicates the company's top-line performance and market demand. A decrease of 3.2% to $987.6M in Q3 2025 is a key concern.)
- Net Income
- The company's profit after all expenses, taxes, and interest have been deducted from revenue. (Measures the company's overall profitability. A 14.8% drop to $38.5M in Q3 2025 highlights a significant decline in earnings.)
- Diluted EPS
- Earnings per share calculated after accounting for all dilutive potential common shares, such as stock options and convertible securities. (A key metric for shareholder value, showing a decrease from $1.60 to $1.40 in Q3 2025.)
- Gross Profit Margin
- The percentage of revenue that exceeds the cost of goods sold. (Indicates the company's efficiency in production and pricing power. A slight improvement to 9.8% is a minor positive despite revenue decline.)
- Operating Expenses
- Costs incurred in the normal course of business, excluding cost of goods sold, such as selling, general, and administrative expenses. (An increase to $60.1M in Q3 2025, driven by SG&A, negatively impacts net income.)
- Cash and Cash Equivalents
- Highly liquid short-term investments that can be readily converted into cash. (Represents the company's immediate liquidity. A decrease to $205.3M needs to be monitored.)
- Total Debt
- The sum of all short-term and long-term borrowings of the company. (Indicates the company's leverage. Stability at $450.0M is noted, but the context of declining revenue is important.)
Year-Over-Year Comparison
Compared to the prior year's third quarter, Plexus Corp experienced a 3.2% decrease in net sales, falling to $987.6 million. This revenue decline was accompanied by a more significant 14.8% drop in net income, resulting in diluted EPS of $1.40 versus $1.60. While the gross profit margin saw a slight improvement to 9.8%, operating expenses increased, further pressuring profitability. The company's cash position also decreased, though total debt remained stable.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on August 1, 2025 regarding PLEXUS CORP (PLXS).